Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
Note: because the trials differed in design, population and duration, the values should not be interpreted as direct comparative efficacy
I went to the pharmacy and they're like, okay, that's going to be $1,400, said Grant, who owns Kapow Social Branding marketing agency
Oxidized roGFP2 WT , PfGrx C88S , and PfGrx C32S/C88S were produced by incubation of the reduced enzymes with 5 mM Diamide for 60 min on ice
10.1007/s00125-019-05021-6 171
US$ 22.84
US$ 20.34
US$ 24.39
US$ 27.67
